MOG and myeloid sarcoma: Using an animal model of MS, Allan and Yates demonstrated that cathepsin L−/− attenuates myelin oligodendrocyte glycoprotein (MOG) antigen presentation and the development of experimental autoimmune encephalomyelitis (EAE) [216].